Fidelity Investments’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$63.4M Buy
4,101,661
+236,563
+6% +$3.66M ﹤0.01% 1299
2025
Q1
$57.5M Buy
3,865,098
+478,810
+14% +$7.12M ﹤0.01% 1302
2024
Q4
$44.8M Buy
3,386,288
+477,370
+16% +$6.32M ﹤0.01% 1424
2024
Q3
$41.4M Buy
2,908,918
+286,052
+11% +$4.07M ﹤0.01% 1454
2024
Q2
$33.9M Buy
2,622,866
+48,626
+2% +$629K ﹤0.01% 1463
2024
Q1
$35.8M Buy
2,574,240
+395,850
+18% +$5.5M ﹤0.01% 1453
2023
Q4
$31.1M Sell
2,178,390
-414,960
-16% -$5.92M ﹤0.01% 1471
2023
Q3
$40.1M Buy
2,593,350
+115,947
+5% +$1.79M ﹤0.01% 1326
2023
Q2
$38.9M Sell
2,477,403
-15,618
-0.6% -$245K ﹤0.01% 1366
2023
Q1
$41.1M Buy
2,493,021
+189,141
+8% +$3.12M ﹤0.01% 1330
2022
Q4
$35.9M Buy
2,303,880
+293,970
+15% +$4.59M ﹤0.01% 1391
2022
Q3
$26.1M Buy
2,009,910
+155,918
+8% +$2.02M ﹤0.01% 1520
2022
Q2
$26M Sell
1,853,992
-594,212
-24% -$8.34M ﹤0.01% 1546
2022
Q1
$35.1M Buy
2,448,204
+525,999
+27% +$7.53M ﹤0.01% 1546
2021
Q4
$26.2M Buy
1,922,205
+144,880
+8% +$1.97M ﹤0.01% 1695
2021
Q3
$29.1M Buy
1,777,325
+219,185
+14% +$3.59M ﹤0.01% 1663
2021
Q2
$26.2M Buy
1,558,140
+271,764
+21% +$4.57M ﹤0.01% 1727
2021
Q1
$23.5M Buy
1,286,376
+330,353
+35% +$6.03M ﹤0.01% 1738
2020
Q4
$17.4M Buy
956,023
+10,129
+1% +$184K ﹤0.01% 1772
2020
Q3
$16.9M Sell
945,894
-42,592
-4% -$760K ﹤0.01% 1633
2020
Q2
$17.7M Buy
988,486
+104,692
+12% +$1.88M ﹤0.01% 1600
2020
Q1
$13.4M Buy
883,794
+328,184
+59% +$4.98M ﹤0.01% 1584
2019
Q4
$11M Sell
555,610
-49,384
-8% -$974K ﹤0.01% 1813
2019
Q3
$10.4M Sell
604,994
-2,103,312
-78% -$36.2M ﹤0.01% 1811
2019
Q2
$47.9M Sell
2,708,306
-4,854,953
-64% -$85.9M 0.01% 1239
2019
Q1
$154M Buy
7,563,259
+7,563,179
+9,453,974% +$154M 0.02% 737
2018
Q4
$1K Buy
+80
New +$1K ﹤0.01% 3425